Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Watts, Eleanor LAppleby, Paul N
Perez-Cornago, Aurora
Bueno-de-Mesquita, H Bas
Chan, June M
Chen, Chu
Cohn, Barbara A
Cook, Michael B
Flicker, Leon
Freedman, Neal D
Giles, Graham G
Giovannucci, Edward
Gislefoss, Randi E
Hankey, Graeme J
Kaaks, Rudolf
Knekt, Paul
Kolonel, Laurence N
Kubo, Tatsuhiko
Le Marchand, Loïc
Luben, Robert N
Luostarinen, Tapio
Männistö, Satu
Metter, E Jeffrey
Mikami, Kazuya
Milne, Roger L
Ozasa, Kotaro
Platz, Elizabeth A
Quirós, J Ramón
Rissanen, Harri
Sawada, Norie
Stampfer, Meir
Stanczyk, Frank Z
Stattin, Pär
Tamakoshi, Akiko
Tangen, Catherine M
Thompson, Ian M
Tsilidis, Konstantinos K
Tsugane, Shoichiro
Ursin, Giske
Vatten, Lars
Weiss, Noel S
Yeap, Bu B
Allen, Naomi E
Key, Timothy J
Travis, Ruth C
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.Published in
Eur Urol 2018; 74(5):585-94Publiekssamenvatting
Experimental and clinical evidence implicates testosterone in the aetiology of prostate cancer. Variation across the normal range of circulating free testosterone concentrations may not lead to changes in prostate biology, unless circulating concentrations are low. This may also apply to prostate cancer risk, but this has not been investigated in an epidemiological setting.PMID
30077399ae974a485f413a2113503eed53cd6c53
10.1016/j.eururo.2018.07.024
Scopus Count
Collections
Related articles
- Circulating Folate and Vitamin B(12) and Risk of Prostate Cancer: A Collaborative Analysis of Individual Participant Data from Six Cohorts Including 6875 Cases and 8104 Controls.
- Authors: Price AJ, Travis RC, Appleby PN, Albanes D, Barricarte Gurrea A, Bjørge T, Bueno-de-Mesquita HB, Chen C, Donovan J, Gislefoss R, Goodman G, Gunter M, Hamdy FC, Johansson M, King IB, Kühn T, Männistö S, Martin RM, Meyer K, Neal DE, Neuhouser ML, Nygård O, Stattin P, Tell GS, Trichopoulou A, Tumino R, Ueland PM, Ulvik A, de Vogel S, Vollset SE, Weinstein SJ, Key TJ, Allen NE, Endogenous Hormones, Nutritional Biomarkers, and Prostate Cancer Collaborative Group
- Issue date: 2016 Dec
- High levels of circulating testosterone are not associated with increased prostate cancer risk: a pooled prospective study.
- Authors: Stattin P, Lumme S, Tenkanen L, Alfthan H, Jellum E, Hallmans G, Thoresen S, Hakulinen T, Luostarinen T, Lehtinen M, Dillner J, Stenman UH, Hakama M
- Issue date: 2004 Jan 20
- Prospective study of sex hormone levels and risk of prostate cancer.
- Authors: Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ
- Issue date: 1996 Aug 21
- Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
- Authors: Platz EA, Leitzmann MF, Rifai N, Kantoff PW, Chen YC, Stampfer MJ, Willett WC, Giovannucci E
- Issue date: 2005 May
- Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
- Authors: Endogenous Hormones and Prostate Cancer Collaborative Group, Roddam AW, Allen NE, Appleby P, Key TJ
- Issue date: 2008 Feb 6